Trial intelligence / Profile preview

4-regimen Chemotherapy in Gastric Cancer

NCT01283204Phase 2Completed

Sponsor
Yonsei University
Start
Mar 2010
Primary completion
Jul 2016
Modality
DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
Countries
1
01

Overview

A Phase 2 trial of tegafur, cisplatin, Paclitaxel Micelles for Injection, docetaxel, oxaliplatin in gastric cancer (GC), sponsored by Yonsei University. Started Mar 2010; status: completed.

02

Drugs

tegafurcisplatinPaclitaxel Micelles for Injectiondocetaxeloxaliplatin
03

Conditions

gastric cancer (GC)

Beyond the preview

Go deeper on NCT01283204.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01283204.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call